Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Research analysts at Atb Cap Markets cut their FY2024 earnings estimates for Cresco Labs in a note issued to investors on Sunday, November 10th. Atb Cap Markets analyst F. Gomes now expects that the company will post earnings per share of ($0.20) for the year, down from their previous estimate of ($0.17). The consensus estimate for Cresco Labs’ current full-year earnings is ($0.19) per share. Atb Cap Markets also issued estimates for Cresco Labs’ Q4 2024 earnings at ($0.03) EPS and FY2025 earnings at ($0.09) EPS.
A number of other equities research analysts also recently commented on the company. Needham & Company LLC reiterated a “hold” rating on shares of Cresco Labs in a research report on Monday, August 12th. Ventum Cap Mkts raised Cresco Labs to a “strong-buy” rating in a report on Friday, August 9th. Finally, Roth Capital upgraded Cresco Labs to a “strong-buy” rating in a research report on Sunday. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Cresco Labs has an average rating of “Buy” and an average price target of $2.50.
Cresco Labs Stock Up 14.3 %
CRLBF opened at $1.44 on Wednesday. The company has a market capitalization of $702.92 million, a PE ratio of -7.10 and a beta of 1.88. The firm has a 50-day simple moving average of $1.58 and a two-hundred day simple moving average of $1.71. The company has a quick ratio of 1.30, a current ratio of 2.00 and a debt-to-equity ratio of 1.76. Cresco Labs has a 52 week low of $1.02 and a 52 week high of $2.65.
About Cresco Labs
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Featured Stories
- Five stocks we like better than Cresco Labs
- Why is the Ex-Dividend Date Significant to Investors?
- Rocket Lab is the Right Stock for the Right Time
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Do ETFs Pay Dividends? What You Need to Know
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.